Chlamydia screening - Yes, but of whom, when, by whom, and with what?

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 286-292

  Mårdh, Per Anders ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MASS SCREENING; PATIENT SELECTION; PELVIC INFLAMMATORY DISEASE; SELF EVALUATION;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

EID: 0034098856     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06240.x     Document Type: Conference Paper

References (26)

1. 1. MÅRDH, P.-A., J. PAAVONEN & M. PUOLAKKAINEN. 1989. Chlamydia. Plenum Press. New York.
2. 2. MÅRDH, P.-A. 1998. Epidemiological aspects of Chlamydia trachomatis genital infections. Gynecol. Forum 3: 21-23.
3. 3. WESTRÖM, L. 1988. Decrease in incidence of women treated in hospital for acute salpingitis in Sweden. Genitourin. Med. 64: 59-63.
4. 4. MÅRDH, P.-A., K. TCHOUDOMIROVA & D. HELLBERG. 1998. Symptoms and signs in single and mixed genital infections in attendees of family planning and youth clinics. Int. J. Gynecol. Obst. 63: 145-152.
5. 5. JASCHEK, G., C.A. GAYDOS, L.E. WELSH, et al. 1993. Direct detection of Chlamydia trachomatis in urine specimens from symptomatic men by using a rapid polymerase chain reaction assay. J. Microbiol. 31: 1209-1212.
6. 6. DOMEIKA, M., M. BASSIRI & P.-A. MÅRDH. 1994. Diagnosis of genital Chlamydia trachomatis infections in asymptomatic males by testing urine by PCR. J. Clin. Microbiol. 32: 2350-2352.
7. 7. LEE, H.H., M.A. CHERNESKY, J. SCHACHTER, et al. 1995. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain assay of urine. Lancet 345: 213-216.
8. 8. BASSIRI, M., P.-A. MÅRDH, M. DOMEIKA, et al. 1997. Multiplex Amplicor® screening PCR kit for Chlamydia trachomatis and Neisseria gonorrhoeae in women attending non-sexually transmitted disease clinics. J. Clin. Microbiol. 35: 2556-2560.
9. 9. MÅRDH, P.-A. & M. DOMEIKA. 1996. Application of DNA-based technologies in the diagnosis of sexually tract diseases. In Sexually Transmitted Infections: Advances in Diagnosis and Treatment. P. Elsner & A. Eichman, Eds.: 174-183. Karger. Zürich.
10. 10. SCHACHTER, J. 1998. Evaluation of diagnostic tests for Chlamydia trachomatis. Gynecol. Forum 3: 26-28.
11. 11. MÅRDH, P.-A., A.N. ELBAGIR & K. STENBERG. 1990. Use of blocking reagent to confirm enzyme immunoassay results in samples from patients with chlamydial conjunctivitis. Eur. J. Clin. Microbiol. Infect. Dis. 9: 292-293.
12. 12. COUDRON, P.E., O.P. FEDORKO, M.S. DAWSON et al. 1986. Detection of Chlamydia trachomatis in genital specimens by the MicroTrak Direct Specimen test. Am. J. Clin. Pathol. 85:89-92.
13. 13. GENC, M., Y. DUTERTRE, M. BJÖRK et al. 1992. Detection of Chlamydia trachomatis in first void urine to identify asymptomatic male carriers. APMIS 100: 645-459.
14. 14. PASTERNACK, R., P. VUORINEN & A. MIETTINEN. 1997. Evaluation of the GenProbe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J. Clin. Microbiol. 35: 836-838.
15. 15. STARY, A., B. NAJIM & H.H. LEE. 1997. Vulval swabs as alternative specimen for ligase chain reaction detection of genital chlamydial infection in women. J. Clin. Microbiol. 35: 836-838.
16. 16. MÅRDH, P.-A, M. BASSIRI, G. CREATSAS, et al. Infectious gynecological health in women attending family planning clinics in Europe. Eur. J. Contracept. Reprod. Health Care, in press.
17. 17. ALLMÄNA RÅD FRÅN SOCIALSTYRELSEN. Förebyggande åtgärder mot chlamydia. SOS, Stockholm (Sweden).
18. 18. HANDSFIELD, H.H., L.L. JASMAN, P.L. ROBERTS, et al. 1986. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 255: 1730-1734.
19. 19. CMO's EXPERT ADVISORY GROUP. 1998. Chlamydia trachomatis. Summary and conclusions. Department of Health, Health Promosion Division. London.
20. 20. WOLNER-HANSSEN, P., N.B. KIVIAT & K.K. HOLMES. 1999. Atypical pelvic inflammatory disease: subacute, chronic, or subclinical upper genital tract infection in women. In Sexually Transmitted Diseases. K.K. Holmes, F. Sparling, et al., Eds.: 615-620. McGraw Hill. New York.
21. 21. MÅRDH, P.-A. & B. HOGG. 1998. Are oral contraceptives masking symptoms of chlamydia cervicitis and pelvic inflammatory disease? Eur. J. Contracept. Reprod. Health Care 3: 41-43.
22. 22. ÖSTERGAARD, L., J.K. MÖLLER, B. ANDERSEN, et al.. 1996. Diagnosis of urogenital Chlamydia infection in women based on mailed samples obtained at home: multi-practice comparative study. Br. Med. J. 313: 1186-1189.
23. 23. GENC, M. & P.-A. MÅRDH. 1996. A cost effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann. Intern. Med. 124: 1-7.
24. 24. PAAVONEN, J., M. PUOLAKKAINEN, M. PAUKKU, et al. 1998. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Am. J. Obst. Gyn. 92: 293-298.
25. 25. GENC, M., L. RUUSUVAARA & P.-A. MÅRDH. 1993. An economic evaluation of screening for Chlamydia trachomatis in adolescent males. JAMA 17: 2057-2064.
26. 26. MÅRDH, P.-A. 1997. Is Europe ready for STD screening? Genitourin. Med. 73: 96-98.